Nuwellis (NUWE) EPS (Weighted Average and Diluted) (QoQ) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Nuwellis | 1.45 Mn | -630,292.49 | 1.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -115.51% |
| Dec 31, 2025 | 2,421.43% |
| Sep 30, 2025 | 100.92% |
| Jun 30, 2025 | -8,739.13% |
| Mar 31, 2025 | 99.67% |
| Dec 31, 2024 | -388.39% |
| Sep 30, 2024 | 109.25% |
| Jun 30, 2024 | -3,184.20% |
| Mar 31, 2024 | -813.26% |
| Dec 31, 2023 | 95.83% |
| Sep 30, 2023 | 50.43% |
| Jun 30, 2023 | -2,116.15% |
| Mar 31, 2023 | -115.87% |
| Dec 31, 2022 | 198.86% |
| Sep 30, 2022 | 9.71% |
| Jun 30, 2022 | 4.19% |
| Mar 31, 2022 | 84.98% |
| Dec 31, 2021 | -37,585.33% |
| Sep 30, 2021 | -4.17% |
| Jun 30, 2021 | 55.56% |
| Mar 31, 2021 | -370.00% |
| Dec 31, 2020 | 128.85% |
| Sep 30, 2020 | 32.90% |
| Jun 30, 2020 | 73.14% |
| Sep 30, 2012 | -16.29% |
| Jun 30, 2012 | 36.31% |
| Sep 30, 2011 | -30.43% |
| Jun 30, 2011 | -23.01% |